Literature DB >> 20228602

Myasthenia gravis accompanied by premature ovarian failure and aggravation by estrogen.

Yi Li1, Bo Xiao, Lan Xiao, Ning Zhang, Huan Yang.   

Abstract

The association of myasthenia gravis (MG) and premature ovarian failure (POF) has rarely been recognized, and the influence of hormone replacement therapy on MG in patients with POF has not been reported. We describe a patient diagnosed with MG and POF, whose myasthenic symptoms were precipitated by estrogen treatment. Such combined clinical symptoms of MG and POF may reflect potentially common autoimmune disease mechanisms, although the precise pathogenesis remains to be defined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228602     DOI: 10.2169/internalmedicine.49.2737

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis.

Authors:  Jacqueline Mays; Cherié L Butts
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

Review 2.  Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Adriana Rojas-Villarraga; July-Vianneth Torres-Gonzalez; Ángela-María Ruiz-Sternberg
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

3.  Balance between Estrogens and Proinflammatory Cytokines Regulates Chemokine Production Involved in Thymic Germinal Center Formation.

Authors:  Nadine Dragin; Patrice Nancy; José Villegas; Régine Roussin; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

4.  Clinical characteristics and relationship between myasthenia gravis and premature ovarian failure: report of two cases.

Authors:  Liming Cao; Weibin Liu; Zhishan Zhu
Journal:  J Int Med Res       Date:  2019-07-25       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.